Bacterially expressed recombinant envelope protein domain III of Japanese encephalitis virus (rJEV-DIII) elicits Th1 type of immune response in BALB/c mice

This publication has 28 references indexed in Scilit:

• Short‐Term Safety of Live Attenuated Japanese Encephalitis Vaccine (SA14–14–2): Results of a Randomized Trial with 26,239 Subjects
  The Journal of Infectious Diseases, 1997
• Systemic immediate-type reactions to gelatin included in Japanese encephalitis vaccines
  Vaccine, 1997
• Effectiveness of live-attenuated Japanese encephalitis vaccine (SA14-14-2): a case-control study
  The Lancet, 1996
• Adverse reactions to Japanese encephalitis vaccine in travellers
  Journal of Infection, 1996
• Homologous and heterologous neutralization antibody responses after immunization with Japanese encephalitis vaccine among Taiwan children
  Journal of Medical Virology, 1994
• Evaluation of the Potency and Safety of Inactivated Japanese Encephalitis Vaccine in US Inhabitants
  The Journal of Infectious Diseases, 1990
• Protection against Japanese Encephalitis by Inactivated Vaccines
  New England Journal of Medicine, 1988
• Safety of a Live-Attenuated Japanese Encephalitis Virus Vaccine (SA14-14-2) for Children
  The American Journal of Tropical Medicine and Hygiene, 1988
• CYCLIC OUTBREAKS OF JAPANESE ENCEPHALITIS AMONG PIGS AND HUMANS1
  American Journal of Epidemiology, 1966
• Ecologic Studies of Japanese Encephalitis Virus in Japan
  The American Journal of Tropical Medicine and Hygiene, 1959